In March 2026, Neuland Laboratories announced plans for a peptide CMC facility in Bonthapally, India designed to produce GLP-1s with room for expansion, complementing originator-led investment and strengthening the API and intermediate supply base
Burger LaF, M EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported 2023 [Available from: Cohen D
Zeidn-Chuli F, Gelain DP, Kolling EA, Rybarczyk-Filho JL, Ambrosi P, Terra SR, Pires AS, da Rocha JB, Behr GA, Moreira JC
Around one-quarter of that is the baby's weight
The program features expert presentations from regulatory scientists across multiple FDA offices, industry leaders from both innovator and generic companies, device manufacturers, and academic researchers, complemented by interactive Q&A panels and small working group discussions for in-person attendees at the end of each day
This glucose-dependent mechanism ensures that insulin is secreted only when necessary, reducing the risk of hypoglycemia once blood sugar returns to normal